Explore the latest in psoriasis from The JAMA Network, including advances in understanding the epidemiology, genetics, and management of the disease.
This cohort study evaluates if a noninvasive test for nonalcoholic steatohepatitis and hepatic fibrosis can be used in patients with psoriasis to aid in determining eligibility for methotrexate therapy, monitor for development of methotrexate-induced hepatotoxic effects, and monitor for worsening of hepatic fibrosis scores during methotrexate therapy.
This cohort study investigates whether patients with psoriasis have an elevated risk of alcohol-related mortality.
This cohort study assesses patterns of use and relative risks of systemic agents for moderate to severe psoriasis in children.
This study examines the association of anchoring with patient willingness to use a monthly injectible medication for psoriasis.
This cohort study investigates the association between change in skin disease severity and change in vascular inflammation at 1 year and characterizes the impact of 1 year of anti–tumor necrosis factor therapy on vascular inflammation in patients with psoriasis.
This Consensus Statement reports on efforts to develop the first set of guidelines for comorbidity screening for patients with pediatric psoriasis based on current evidence.
This cohort study explores the association between uveitis and psoriasis without psoriatic arthritis.
This case report describes a targeted treatment option in a patient with pityriasis rubra pilaris using blockade of the interleukin 23–helper T cell 17 pathway.
This population-based cohort study examines the link between bariatric surgery and improvement in psoriasis symptoms.
This case report describes the response to interleukin (IL)-17 inhibition in a male adolescent with severe manifestations of IL-36 receptor antagonist deficiency (DITRA).
This study evaluates waist-to-height ratio in children with psoriasis as a potentially superior measure of central adiposity and increased cardiovascular risk than is body mass index.
This cross-sectional study compares coronary artery calcium scores in patients with moderate to severe psoriasis, type 2 diabetes, and healthy controls.
This case report describes successful treatment of refractory pityriasis rubra pilaris with secukinumab.
This study investigates whether modulation of inflammation by treatment with biologic agents is associated with progression of coronary artery disease in patients with severe psoriasis.
A woman in her early 50s presented with a 1- to 2-year history of outbreaks of mildly pruritic “flowers” on her skin occurring in crops of 3 to 4 on arms, legs, trunk, and buttocks that would last a few months before spontaneously resolving without scarring. What is your diagnosis?